These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 24909277)
21. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695 [TBL] [Abstract][Full Text] [Related]
22. Construction and immunogenicity of the DNA vaccine of Mycobacterium Tuberculosis dormancy antigen rv1733c. Zhang W; Jiang H; Bai YL; Kang J; Xu ZK; Wang LM Scand J Immunol; 2014 May; 79(5):292-8. PubMed ID: 24498941 [TBL] [Abstract][Full Text] [Related]
23. Chemokine receptor-mediated delivery of mycobacterial MPT51 protein efficiently induces antigen-specific T-cell responses. Uchijima M; Nagata T; Koide Y Vaccine; 2008 Sep; 26(40):5165-9. PubMed ID: 18456373 [TBL] [Abstract][Full Text] [Related]
24. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice. Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320 [TBL] [Abstract][Full Text] [Related]
25. [Immune effects research of interleukin 12 and Mycobacterium tuberculosis ESAT-6 antigen combined DNA immunization]. Hao M; Bao L; Gao L Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):477-81. PubMed ID: 17672309 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice. Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene. Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317 [TBL] [Abstract][Full Text] [Related]
28. [Preparation of TAT-Ag85B protein vaccine and evaluation of its anti-Myobacterium tuberculosis effect]. Zhang R; Wang W; Hu D; Wang W; Xing Y; He J; Dai J; Wu J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):49-53. PubMed ID: 25575059 [TBL] [Abstract][Full Text] [Related]
29. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice. Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431 [TBL] [Abstract][Full Text] [Related]
30. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines. Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027 [TBL] [Abstract][Full Text] [Related]
31. [Immunity characteristics induced by a genetic vaccine expressing Ag85B-ESAT6 fusion protein]. Shi CH; Wang XW; Zhu DS; Xu ZK; Bai YL; Xue Y Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):777-80. PubMed ID: 16324275 [TBL] [Abstract][Full Text] [Related]
32. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis]. Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983 [TBL] [Abstract][Full Text] [Related]
33. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+. Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506 [TBL] [Abstract][Full Text] [Related]
34. Specific immune responses induced by multi-epitope DNA derived from Mycobacterium tuberculosis DosR antigens. Moradi J; Izad M; Tabrizi M; Mosavari N; Esmaeili B; Feizabadi MM Acta Microbiol Immunol Hung; 2018 Jun; 65(2):193-209. PubMed ID: 29552899 [TBL] [Abstract][Full Text] [Related]
35. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592 [TBL] [Abstract][Full Text] [Related]
36. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis. Derrick SC; Yang AL; Morris SL Infect Immun; 2005 Nov; 73(11):7727-35. PubMed ID: 16239577 [TBL] [Abstract][Full Text] [Related]
37. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis. Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075 [TBL] [Abstract][Full Text] [Related]
38. Immunotherapeutic effects of Mycobacterium tuberculosis rv3407 DNA vaccine in mice. Liang Y; Zhao Y; Bai X; Xiao L; Yang Y; Zhang J; Wang L; Cui L; Wang T; Shi Y; Zhao W; Wu X Autoimmunity; 2018 Dec; 51(8):417-422. PubMed ID: 30632804 [TBL] [Abstract][Full Text] [Related]
39. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis. West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485 [TBL] [Abstract][Full Text] [Related]
40. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines. Hu Z; Jiang W; Gu L; Qiao D; Shu T; Lowrie DB; Lu SH; Fan XY J Mol Med (Berl); 2019 Dec; 97(12):1685-1694. PubMed ID: 31786669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]